8-K
Current Report
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-026946
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading ef20052517_8k.htm…